Metraipolis › archive › dc_fc42cfdb8da6

Efficacy and safety of immunotherapy rechallenge in second-line treatment after failure of first-line immune checkpoint inhibitors combined with chemotherapy… — Europe PMC PMID:41451202

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41451202
DOI
10.3389/fimmu.2025.1697712
License (as archived)
solo-consultazione
Archived
2026-11-07T18:32:23.501Z
SHA-256 of the archived text
f517d6bc5710d71d0388b07056657d0c46abd83b231df26a28ad9ee48109626e
Stable URL of this page
https://metraipolis.com/documento/dc_fc42cfdb8da6

How to cite

Efficacy and safety of immunotherapy rechallenge in second-line treatment after failure of first-line immune checkpoint inhibitors combined with chemotherapy… — Europe PMC PMID:41451202 — Europe PMC (en), https://europepmc.org/article/MED/41451202 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc42cfdb8da6 (Metraipolis archive dc_fc42cfdb8da6, sha256 f517d6bc5710d71d0388b07056657d0c46abd83b231df26a28ad9ee48109626e)
BibTeX
@misc{dcfc42cfdb8da6,
  title = {Efficacy and safety of immunotherapy rechallenge in second-line treatment after failure of first-line immune checkpoint inhibitors combined with chemotherapy… — Europe PMC PMID:41451202},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41451202},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc42cfdb8da6; sha256 f517d6bc5710d71d0388b07056657d0c46abd83b231df26a28ad9ee48109626e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41451202. Agents can read the archived copy with the MCP tool read_document.